Atherosclerosis risk is higher in continuous ambulatory peritoneal dialysis patients than in hemodialysis patients

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Vascular Biology

Background:

• Cardiovascular disease is a leading cause of mortality in dialysis patients.
• Previous studies have yielded conflicting results regarding the prevalence of atherosclerosis in continuous ambulatory peritoneal dialysis (CAPD) versus hemodialysis (HD) patients.
• Identifying factors contributing to atherosclerosis in dialysis modalities is crucial for patient management.

Purpose of the Study:

• To compare the extent of atherosclerotic changes between CAPD and HD patients.
• To identify specific risk factors associated with increased atherosclerosis in dialysis patients.
• To elucidate potential differences in atherosclerosis development between CAPD and HD modalities.

Main Methods:

• A comparative study involving 65 CAPD patients and 109 age-, gender-, and duration-of-dialysis-matched HD patients.
• Ultrasonographic measurement of carotid artery intima-media thickness (CIMT) to assess atherosclerosis.
• Comprehensive analysis of known atherosclerosis risk factors, including lipid profiles, inflammatory markers, and parathyroid hormone levels.

Main Results:

• CAPD patients exhibited significantly greater atherosclerotic changes compared to HD patients.
• Serum total cholesterol, low-density lipoprotein cholesterol (LDL-C), and lipoprotein (a) [Lp(a)] levels were significantly elevated in CAPD patients.
• No significant differences were observed in other measured risk factors between the two groups.

Conclusions:

• Continuous ambulatory peritoneal dialysis is associated with a higher burden of atherosclerosis compared to hemodialysis.
• Elevated serum total cholesterol, LDL-C, and Lp(a) are key factors contributing to increased atherosclerosis in CAPD patients.
• These findings highlight the need for targeted cardiovascular risk management in CAPD populations.